NATO AIR
Senior Member
here is newsweek's take on the events leading up to and after the flu shot fiasco worried the nation
The Flu Shot Fiasco
The shortage has put millions into a panic. Spotty supply is the immediate problem. Caring for our country's public health is the bigger issue
By Geoffrey Cowley
Newsweek
Nov. 1 issue - If you needed a flu shot last week, southern California was not the place to find it. Three weeks into the great vaccine debacle of 2004, L.A.'s Cedars-Sinai Hospital was limping along on 10 percent of its usual supply. There was no flu vaccine at San Diego's Camp Pendleton Marine Corps base, and no word from the Pentagon on when or whether the facility's 60,000 personnel might finally get their shots. Across the border in Tijuana, meanwhile, Dr. Enrique Chacon was cheerfully administering freshly bottled Aventis Pasteur flu vaccine. There are no waiting lists at his well-scrubbed Grupo Pediatrico children's clinic, no restrictions on who can get a shot. And though many of Chacon's patients are locals, he stands ever ready to help a northerner in need. "Viruses cross borders without a visa," he says. "If there is influenza on one side, there will be influenza on the other. We need to vaccinate everyone."
If only we could. As recently as three weeks ago, health experts assumed that 100 million Americans would have access to flu shots this fall. That was before British authorities shut down a Liverpool production plant operated by the U.S. company Chiron. Overnight, the U.S. vaccine supply shrank by nearly half, prompting restrictions on access, a surge in demand and a mounting sense of panic among doctors, patients and parents.
Scalpers are now peddling scarce vaccine lots at 10 times the usual price. Hospitals are turning away old folks and cancer patients who could die from lack of a flu shot. And with the presidential campaign in its final weeks, both candidates are trying to sway voters on the issue. By President George W. Bush's account, the vaccine crisis is a reminder of the need for liability reform, but no cause for alarm. "We have healthy supplies of antiviral medicines and vaccines to help keep you safe from the flu and its complications," Health Secretary Tommy Thompson said in a press briefing last week. Sen. John Kerry chides the president for failing to prevent the fiascoand prays that the administration's blithe reassurances will backfire. "People are red-in-the-face mad about this," his spokesman David Wade says. "When Bush said in the last debate that he just wouldn't get a flu shot, that crystallized the impression that he's out of touch."
The truth is, neither candidate had a lot to say about influenza, or the vaccine supply, until the system collapsed this month. The flu virus is a wily and dangerous foe. It strikes as many as 56 million Americans each year, causing 200,000 hospitalizations and 36,000 deaths. Routine vaccination can almost always prevent the condition. But profit-conscious drug companies have fled the business in droves in recent years, leaving the health system ever more vulnerable to shortages and interruptions in supply. Health experts have spent two decades warning that our system for producing vaccines is dangerously fragile and suggesting ways to make it more secure. Politics aside, they agree that the current crisis is not a fluke but a predictable consequence of inaction. "We've been on precarious ground for decades now," says Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "The accident that was waiting to happen just happened."
With luck, the medical fallout could still be minimal this year. The anticipated strain of flu virus is a close variant of last year's, meaning that previously exposed people should have at least partial immunity. And though Chiron's withdrawal leaves only one major manufacturer, Aventis Pasteur, to pick up the slack, there should still be 61 million doses on the U.S. market this winter58 million vials of injectable vaccine from Aventis, plus 3 million doses of MedImmune's FluMist nasal vaccine. That's considerably less than the 85 million doses administered last year, but federal health officials have developed a voluntary triage system to boost the effect of the limited supply. Instead of promoting vaccination for everyone older than 6 months, the U.S. Centers for Disease Control and Prevention are asking healthy people between 2 and 64 to skip their shots this year so that health workers can direct all the available vaccine to old folks, young children, pregnant women and people with chronic illnesses. CDC is also trying to work with Aventis to ship vaccine to health departments, VA hospitals and clinics serving high-risk patients
get the rest @ (its a three page story)
http://www.msnbc.msn.com/id/6315714/site/newsweek/